A metabolomics-driven model for early remission prediction following vedolizumab treatment in patients with moderate-to-severe active ulcerative colitis
| Autor: | Jiang, Leilei, Liu, Xiaoming, Su, Yue, Chen, Yujie, Yang, Shaozhi, Ke, Xiquan, Yao, Kunhou, Guo, Zhiguo |
|---|---|
| Zdroj: | In International Immunopharmacology 15 February 2024 128 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect